COGT vs DOCU · $5.75B cap vs P/E 15, rev $1.71B
Cogent Biosciences Inc (COGT) versus DocuSign Inc (DOCU) — a side-by-side from cached financials, not a winner call.
Cogent Biosciences Inc (COGT) is a biotechnology company listed on NASDAQ.
DocuSign Inc (DOCU) is a software - application company listed on US.
COGT does not have a complete income-statement cache yet.
Latest reported DOCU revenue for 2026-07-31 was $1.71B. Net income was $155.9M. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
COGT currently screens at market cap $5.75B. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Not investment advice. Open the COGT and DOCU stock pages for the full models.
Not investment advice.